OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
OncoHost has raised €6.6M across 1 funding round, most recently a round in Jan 2021. Based in Binyamina, Israel; founded 2017; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€6.6M
€6,611,024
Funding rounds
1
Investors
0
distinct backers
Active since
2021-01
latest 2021-01
Funding by year
EUR raised per yearOncoHost — funding by year — interactive chart.
Data table
| OncoHost — funding by year | |
|---|---|
| 2021 | €6.6M |
Signals
Medium confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-01-21 | Other | €6.6M | — | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Trax€789MIsrael · Software
Global coverage: FundingData